Literature DB >> 26752909

Mononeuritis multiplex in acquired amegakaryocytic thrombocytopenia.

Firosh Khan1, Abdulkhader Shehna2, Lekha Mukundan3.   

Abstract

Mononeuritis multiplex involves inflammation of two or more nerves, typically in unrelated parts of the body. It has been well described in bleeding disorders like idiopathic thrombocytopenic purpura (ITP) and Hemophilia. Acquired amegakaryocytic thrombocytopenia (AAT) is a bleeding diathesis characterized by thrombocytopenia but with reduced number of megakaryocytes in the bone marrow, as against ITP. Though AAT is a well described entity, peripheral nervous system manifestations have not been described so far. We report a young man who has presented with bleeding diathesis and mononeuritis multiplex due to AAT. The mechanism of development of mononeuritis multiplex and treatment options are discussed.

Entities:  

Keywords:  Amegakaryocytic thrombocytopenia; mononeuritis multiplex; purpura

Year:  2015        PMID: 26752909      PMCID: PMC4692023          DOI: 10.4103/0976-3147.165351

Source DB:  PubMed          Journal:  J Neurosci Rural Pract        ISSN: 0976-3155


  9 in total

Review 1.  Amegakaryocytic thrombocytopenic purpura.

Authors:  K Harjai; M Shah; A Pant; P Kale; A V Pathare
Journal:  J Postgrad Med       Date:  1992 Apr-Jun       Impact factor: 1.476

2.  Painful mononeuritis multiplex in idiopathic thrombocytopenic purpura.

Authors:  Sudhir Kumar
Journal:  Indian Pediatr       Date:  2005-06       Impact factor: 1.411

3.  A purpuric rash and mononeuritis multiplex.

Authors:  David E Winchester; Kristin Guilliams
Journal:  Am Fam Physician       Date:  2008-02-15       Impact factor: 3.292

4.  Successful treatment of amegakaryocytic thrombocytopenic purpura with cyclosporine.

Authors:  W Hill; R Landgraf
Journal:  N Engl J Med       Date:  1985-04-18       Impact factor: 91.245

5.  c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.

Authors:  M Ballmaier; M Germeshausen; H Schulze; K Cherkaoui; S Lang; A Gaudig; S Krukemeier; M Eilers; G Strauss; K Welte
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

6.  Juvenile cyclic amegakaryocytic thrombocytopenia: a novel entity.

Authors:  Marrie Bruin; Marloes R Tijssen; Marc Bierings; Masja de Haas
Journal:  J Pediatr Hematol Oncol       Date:  2005-03       Impact factor: 1.289

Review 7.  Hepatitis B virus (HBV) and autoimmune disease.

Authors:  Ram Maya; M Eric Gershwin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

8.  Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies.

Authors:  R Hoffman; E Bruno; J Elwell; E Mazur; A M Gewirtz; P Dekker; A E Denes
Journal:  Blood       Date:  1982-11       Impact factor: 22.113

Review 9.  Immune thrombocytopenia in adults: an update.

Authors:  Swapna Thota; Gaurav Kistangari; Hamed Daw; Timothy Spiro
Journal:  Cleve Clin J Med       Date:  2012-09       Impact factor: 2.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.